Saturday, November 8, 2014

Fight For Your Liver: Investment Commentary/ Why investors will be following the liver meeting

Investment Commentary
Meg Tirrell tells us which biotech companies investors will be watching ahead of an annual liver disease conference.


No comments:

Post a Comment